About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Piramal Pharma Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Medicamen Biotech
367.3
42.5
13.08
6.52
56.36
4580
-28.88
0.27
165.97
NGL Fine-Chem
1515
25.75
1.73
29.06
52.14
57
-28.03
0.12
452.6
Jenburkt Pharma
1087
21.85
2.05
73.5
14.79
1114
4.52
1.66
389.23
JB Chem & Pharma
1711
18.65
1.1
43.24
39.57
2266
-10.19
0.91
206.14
Torrent Pharma
3606.7
16.55
0.46
58.21
61.96
1854
6.3
0.89
224.32
Kwality Pharma
908.75
15.15
1.7
41.88
21.7
10282
11.05
0
255.44
Laurus Labs
936.75
12.9
1.4
9.44
99.24
107489
101.54
0.13
84.15
Sai Life Sciences
889.95
10.35
1.18
8.27
107.63
8137
0
103.76
Wanbury
241.1
6.75
2.88
12.33
19.56
4010
1.09
0
15.69
Zydus Lifesciences
1006.6
6.7
0.67
44.31
22.72
58469
0.14
1.09
210.64
Eris Lifesciences
1592.15
6.35
0.4
11.77
135.26
15615
19.79
0.46
183.9
Albert David
807
6.35
0.79
11.02
73.2
288
-42.36
0.62
687.7
Strides Pharma Scien
813.7
6.25
0.77
6.48
125.59
9629
-50.29
0.49
346.37
Sun Pharma Inds.
1696
5.7
0.34
20
84.81
117188
-10.57
0.94
101.45
Shree Ganesh Remed.
498.85
5.4
1.09
17.06
29.25
3677
-36.74
0
113.1
Parmax Pharma
34.75
5.01
16.85
-7.67
0
2353
-19.07
0
-1.71
Haleos Labs
1126.3
4.95
0.44
66.38
16.97
3
-21.79
0.13
652.19
Solara Active Pharma
604.5
4.65
0.78
4.52
133.73
39656
-26.62
0
271.53
Mangalam Drugs&Org.
70.48
3.36
5.01
-6
0
372
-39.35
0
93.92
Mankind Pharma
2450
3.25
0.13
43.95
55.75
6433
-7.23
0
353.77
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.